Inhalation Sciences gets large order from AstraZeneca
STOCKHOLM, SVERIGE – 27 september, 2017. Inhalation Sciences (ISAB) has received an order for a complete PreciseInhale system, including all its test modules, from AstraZeneca.ISAB, which recently carried out an oversubscribed share issue ahead of its listing on AktieTorget in Stockholm, develops and sells advanced lab equipment for inhalation R&D that measures how particles in inhaled air affect our health. ISAB has successfully delivered PreciseInhale to a number of other key customers and Key Opinion Leaders, including Chiesi Farmaceutici, Kings College and Dow Chemicals. AstraZeneca